World Intellectual Property Organization

Questionnaire on Exceptions and Limitations to Patent Rights

Table and links to the replies received from member states and regional offices to the SCP.

  • Questionnaire DOC, questionnaire PDF, questionnaire
Country Section 1: General Section 2: Private and/or non-commercial use Section 3: Experimental use and/or scientific research Section 4: Preparation of medicines Section 5: Prior use Section 6: Use of articles on foreign vessels, aircraft and land vehicles Section 7: Acts for obtaining regulatory approval from authorities Section 8: Exhaustion of patent rights Section 9: Compulsory licensing and/or government use Section 10: Exceptions and limitations related to farmers' and/or breeders' use of patented invnetions Section 11: Other exceptions and limitations

Albania
[PDF]

x x x x x x x 25
x x x

Algeria
[PDF]

x x x x x x x
Armenia
[PDF]
x x x x x x x x 1

Australia
[PDF1]
[PDF2 update]

x

* 2

 x 31

x x

x 31 

x x
Austria
[PDF]
x x x x x x x x x
Azerbaijan
[PDF]
x x x x x x x x
Bhutan
[PDF]
x x x x x x  
Bosnia and Herzegovina
[PDF]
x x x x  x x x  x x  x
Brazil
[PDF]
x x x x x x x x x  3 x

Bulgaria
[PDF]

x x x x x x x x x x
Burkina Faso
[PDF]
x x  x  x x x x
Canada
[PDF]
x x x x x x x * 20
Chile
[PDF]
x 4 x x x 1  x
China
[CN] [EN]
x x x x x x x x
Congo
[PDF]
x x x
Costa  Rica
[PDF]
x x x x x5 x x x
Croatia
[PDF]
x x x x x x x x x x
Cyprus
[PDF]
x x x x x x
Czech Republic
[PDF]
x x x x x x x x x 1 x
Democratic People's Republic of Korea
[PDF]
x *6
x x6 x7
x x1

 

Denmark
[PDF]
x x x x x x x x x 1 x
Djibouti
[PDF]
x x 1 * 23
Dominican Republic
[PDF]
x x x x x x x 
El Salvador
[PDF] [Note]
x x x x x x x x 1
Finland
[PDF]
x x x x x x x  x  x x
France
[PDF]
x x x x x x x x x x
Gambia
[PDF]
x x x x
Georgia
[PDF]
x x x x x x
Germany
[PDF]
x x x x x x x x x 1 x x
Greece
[PDF]
x x x x x x x x x x
Honduras
[
PDF]
x x x x 1
Hong Kong
[PDF]
x x x x x  x x x
Hungary
[PDF]
x x x x x x x x x 1

India
[PDF]

x x x   x x x32 x x x  
Indonesia
[PDF]
x x 9 x x
Israel
[PDF]
x x x x x x x 14 x * 16 x
Italy
[PDF]
x x x x x x x * 10
Jamaica
[PDF]
x  
Japan
[PDF]
x x x x x x x x    

Jordan
[PDF]

x x x  – x x x  –

Kenya
[PDF]

x x x  – x x x x x x x
Kyrgyzstan
[PDF]
x  – x x x x
Latvia
[PDF]
x x x x x x x x x x
Lithuania
[PDF]
x x x x x x x x x x
Madagascar
[PDF]
x x x x x x
Mauritius
[PDF]
x x x x x
Mexico
[PDF]
x x x x x x x x 1 x
Monaco
[PDF]
x x 1
Morocco
[PDF]
x x x x x x * 11 x x
Netherlands
[PDF]
x x x x x x x x x 12
New Zealand
[PDF]
x x * 13 x x x 14 x
Norway
[PDF]
x x x x x x x x x x x
Oman
[PDF]
x x 24 x x x x x x x x
Pakistan
[PDF]
x x x x x x x x
Peru
[PDF]
x x x x x x x x 1
Philippines
[PDF]
x x x x x x x x 15 x
Poland
[PDF]
x x x x x x  x x x x
Portugal
[PDF]
x x x x x x  x x x x 17
Qatar
[PDF]
 x  –  x x x 26
* 27
x  –
Republic of Korea
[PDF]
x x x x x x x x * 18
Republic of Moldova
[PDF]
x  x  x x  x x x x x 
Romania
[PDF]
x  x  x x  x  * 29
x x  –
Russian Federation
[RU] [EN]
x  x  x x x x  x x x
Sao Tome and Principe
[EN] [ES]
x x x x x x x
Serbia
[PDF]
x x x x x x x x 1 x
Slovakia
[PDF]
x  x x x  x x  x  x x 1 x
South Africa
[
PDF]
x  x  * 28
x  x x x  x  –
Spain
[PDF]
x  x x x  x x x x x 1 x 11 x 
Sri Lanka
[PDF]
x  x x x x x x
Sweden
[PDF]
x  x x x x  x  x x x 1 x
Switzerland
[PDF]
x x x x x x x x 1 x x
Tajikistan
[PDF]
x x x x x x x x x
Thailand
[PDF]
x x x x x x x x
Turkey
[PDF]
x  x x x x x x x x 1
Uganda
[PDF]
x x x  – x x x x x31
Ukraine
[PDF]
x  x x x x   x x x
United Kingdom
[PDF]
x x  x x x x  x x x x
United Republic of Tanzania
[PDF]
x x x x x x
United States of America
[PDF]
x x  x x x x x  * 19 * 20
Viet Nam
[PDF]
x x x x x x x x x x
Zambia
[PDF]
x x x x
Zimbabwe
[PDF]
x x x x x x
Eurasian Patent Office (EAPO)
[PDF]
x  x  x x x  x  21 x 22

1. Only compulsory licensing, no government use exception.
2. There is no statutory provision related to private and/or non-commercial use exception.  However, it is considered that a non-commercial use defense may arise under common law.
3. Only exception relating to the breeders' use of patented inventions, no exception relating to the farmers' use of patented inventions.
4. There is no statutory exception related to the use of articles on foreign vessels, aircrafts and land vehicles. However, Article 5ter of the Paris Convention and Article 27 of the Chicago Convention applies.
5. There is no national statutory provision. However, Article 5ter of the Paris Convention applies.
6. The response refers to Article 33 of the Invention Law of the Democratic People’s Republic of Korea. However no express exception for private and non-commercial use is provided by statutory law.
7. Response was not provided. However, the exception is provided by Article 33(c) of the Invention Law of the Democratic People’s Republic of Korea.
8. There is no express statutory provision on prior use.
9. The response states that there is no such exception, but refers to government use for public health reasons.
10. The response refers to Section VII (New Plant Varities) of the Industrial Property Code of 2005.
11. The response refers to a future amendment of the legal framework.
12. Only exceptions relating to the farmers' use of patented inventions, no exception relating to the breeders' use of patented inventions.
13. While there is no prior use exception, a prior secret use constitutes a round for revocation of the patent.
14. The applicable type of exhaustion regime is uncertain.
15. International exhaustion is applied in relation to drugs and medicines, national exhaustion is applied for all other products.
16. The response refers to exceptions to plant variety protection.
17. While there is no government use exception, the response refers to the law regarding the expropriation of patents.
18. The response refers to exceptions available under the Seed Industry Act.
19. The response states that there are no such exceptions in patent protection, but refers to farmers' and breeders' use in plant variety protection.
20. The response refers to mechanisms in competition law.
21. The applicable type of exhaustion regime is defined according to the national laws of Contracting States.
22. Only compulsory licensing, government use exception is provided according to the national laws of Contracting States.
23.  The response refers to compulsory licenses.
24.  The exception applies to patents on plants and plant varieties only.
25. The response refers to Article 38 of Law No 9947.
26.  The response refers to Article 15 of Qatar Decree Law No. (30), 2006.
27.  The response refers to Article 11 of Qatar Decree Law No. (30), 2006.
28.  The response refers to Section 26b of the Patent Act 57 of 1978.
29. There is no express statutory provision related to acts for obtaining regulatory approval from authorities. However, the exception is applied in case of obtaining an authorization to put a medicine or plant protection product on the market.
30.  Please see PDF2 update which contains updated information related to experimental use and scientific research exception, as well as exception relating to acts for obtaining regulatory approval from authorities, submitted on June 28, 2013.
31.  The response refers to sui generis system for protection of plant breeders' rights.
32.  The response states that no such provisions exist under the Indian Patents Act, but refers to the Protection of Plant Varieties and Farmers' rights Act of 2001.

 

Explore WIPO